Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Zura Bio granted an option to purchase up to 600,000 Class A Ordinary Shares to Muzammil Mustufa, the company's new Chief Business Officer. The option has an exercise price of $4.80 per share, which is equal to the closing price on May 13, 2026. The option will vest over four years, with one-fourth vesting on the one-year anniversary of the vesting commencement date and the remaining shares vesting in equal quarterly installments.
Key figures
- Offering Price
- 4.8
- Shares Offered
- 600000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.